Antiretroviral Therapy Journal Articles

• DTG/3TC as a First-Line Regimen in a Test-and-Treat Setting Is this two-drug combination ART regimen an effective option for newly diagnosed individuals in a test-and-treat setting?
  AIDS, September 23, 2021
• Polypharmacy and HIV Suppression in Older People With HIV Might the use of multiple medications impact HIV viral suppression among older adults?
  HIV Medicine, September 21, 2021
• Initial ART Response Among Older People Living With HIV How do the immunological and virological responses to ART among older adults differ from that of younger people, and what are the implications?
  HIV Medicine, September 14, 2021
• COVID-19 Testing, Characteristics, and Outcomes in HIV How do the rates of COVID-19 testing and complications among individuals with HIV differ from that of HIV-uninfected patients?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, September 13, 2021
• Headache in Transgender and Gender-diverse Patients This review summarizes the unique aspects of managing headache in transgender individuals. How might potential causes and management differ from that of cisgender persons?
  Headache, September 07, 2021
• Tolerability of Four-Drug Combination ART in Primary HIV-1 What are the benefits of initiating four-drug ART regimens, and how well are they tolerated?
  HIV Medicine, September 07, 2021
• Targeted and Immunotherapies in BRAF Mutant Melanoma Review the clinical considerations for choosing between MAPK inhibitors and immune checkpoint inhibitors as first-line therapy for BRAF mutant advanced melanoma.
  The British Journal of Dermatology, September 01, 2021
• In-Hospital Mortality in HIV Patients Presenting to the ED Certain clinical and laboratory variables may be associated with in-hospital mortality among HIV patients presenting to the ED. What are they?
  HIV Medicine, August 27, 2021
• Safety and Response to the SARS-CoV-2 mRNA Vaccine in HIV Early data provides insight into the safety and development of antibodies among people with HIV who received the first dose of the SARS-CoV-2 mRNA vaccine.
  AIDS, August 24, 2021
• Changes in ALT Levels After Switching From TDF to TAF in HIV How might an ART treatment switch from TDF to TAF impact alanine aminotransferase levels, and what are the implications?
  HIV Medicine, August 20, 2021
• Estimated Annual Number of HIV Infections -- U.S. 1981-2019 This report shows that HIV incidence decreased substantially from the 1980s through 2019, but disparities remain.
  Morbidity & Mortality Weekly Report, August 18, 2021
• In-Utero Exposure to Zidovudine in Uninfected Newborns What do we know about the potential effects of in-utero zidovudine exposure? Is it safe to use during pregnancy?
  AIDS, August 10, 2021
• HIV Treatment, Comorbidity and Substance Use Among MSM While timely ART initiation has improved among MSM living with HIV, the complex health needs of this population continues to evolve.
  HIV Medicine, August 06, 2021
• Predictors of HIV-1 Virologic Failure to CAB and RPV Which factors may be associated with virologic failure to these two long-acting antiretroviral drugs?
  AIDS, July 26, 2021
• P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke This review compared the effectiveness and safety of DAPT therapy with P2Y12 inhibitors and aspirin versus aspirin monotherapy in patients with mild ischemic stroke or high-risk TIA.
  Stroke, July 22, 2021
• Switching to DTG plus bDRV in Treatment-Experienced HIV-1 Is this dual regimen an effective switch strategy in highly treatment-experienced HIV-1 patients?
  HIV Medicine, July 15, 2021
• The Burden of Non-Communicable Diseases, Mortality in PLHIV Non-communicable diseases are more prevalent among people living with HIV, which may also contribute to an increased risk of mortality. What can be done to improve survival and quality of life?
  HIV Medicine, July 08, 2021
• Outcomes Associated With Change From TDF to TAF in HIV-1 A new study looks at the effects of a treatment switch from tenofovir disoproxil fumarate to tenofovir alafenamide-containing ART regimens among HIV-1-infected patients
  HIV Medicine, July 01, 2021
• eGFR in HIV and HCV-coinfected Patients Receiving DAAs+ART This study assessed the changes in eGFR, a surrogate marker of renal function, in HIV/HCV-coinfected patients receiving sofosbuvir treatment for HCV along with antiretroviral therapy.
  Journal of Viral Hepatitis, June 29, 2021
• Effectiveness and Safety of DTG Two-Drug Regimens in HIV Could these two-drug ART regimens provide a safe and effective treatment option for virologically suppressed people living with HIV?
  HIV Medicine, June 24, 2021